President Bush signed a Drug Safety bill giving the FDA more money and new powers to police potentially serious side effects of marketed prescription drugs. These amendments were introduced largely as a response to a string of recent high profile drug safety controversies. The bill gives the FDA the authority to require new warnings on drugs, order post-approval safety studies or limit distribution due to side effect considerations. Drug and device makers will also be required to post basic results for clinical trials on a public database. The legislation, which has received the support of the pharmaceutical industry, also increases fees paid by pharmaceutical companies to fund these initiatives.

For more information, please see: